Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Sandy Feng, MD, PhD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentSurgery
    Address505 Parnassus Ave, Moffitt
    San Francisco CA 94143
    Phone415-353-8725

       ORNG Applications 
       Websites
       Featured Videos
       In The News
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Lai JC, Feng S, Terrault NA, Lizaola B, Hayssen H, Covinsky K. Frailty Predicts Waitlist Mortality in Liver Transplant Candidates. Am J Transplant. 2014 Jun 16.
        View in: PubMed
      2. Parekh J, Roll GR, Feng S, Niemann CU, Hirose R. Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation. Clin Transplant. 2013 Jul-Aug; 27(4):E424-30.
        View in: PubMed
      3. Lai JC, Feng S, Vittinghoff E, Roberts JP. Offer patterns of nationally placed livers by donation service area. Liver Transpl. 2013 Apr; 19(4):404-10.
        View in: PubMed
      4. Lai JC, Feng S, Roberts JP. An examination of liver offers to candidates on the liver transplant wait-list. Gastroenterology. 2012 Nov; 143(5):1261-5.
        View in: PubMed
      5. Parekh J, Corley DA, Feng S. Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation. Am J Transplant. 2012 Aug; 12(8):2181-7.
        View in: PubMed
      6. Lai JC, Roberts JP, Vittinghoff E, Terrault NA, Feng S. Patient, center and geographic characteristics of nationally placed livers. Am J Transplant. 2012 Apr; 12(4):947-53.
        View in: PubMed
      7. Feng S, Ekong UD, Lobritto SJ, Demetris AJ, Roberts JP, Rosenthal P, Alonso EM, Philogene MC, Ikle D, Poole KM, Bridges ND, Turka LA, Tchao NK. Complete immunosuppression withdrawal and subsequent allograft function among pediatric recipients of parental living donor liver transplants. JAMA. 2012 Jan 18; 307(3):283-93.
        View in: PubMed
      8. Nijagal A, Fleck S, Hills NK, Feng S, Tang Q, Kang SM, Rosenthal P, MacKenzie TC. Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant. 2012 Feb; 12(2):409-19.
        View in: PubMed
      9. Singh KM, Phung YT, Kohla MS, Lan BY, Chan S, Suen DL, Murad S, Rheault S, Davidson P, Evans J, Singh M, Dohil S, Osorio RW, Wakil AE, Page K, Feng S, Cooper SL. KIR genotypic diversity can track ancestries in heterogeneous populations: a potential confounder for disease association studies. Immunogenetics. 2012 Feb; 64(2):97-109.
        View in: PubMed
      10. Lai JC, Feng S, Roberts JP, Terrault NA. Gender differences in liver donor quality are predictive of graft loss. Am J Transplant. 2011 Feb; 11(2):296-302.
        View in: PubMed
      11. Feng S. Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant. 2010 May; 10(5):1155-62.
        View in: PubMed
      12. Parekh J, Bostrom A, Feng S. Diabetes mellitus: a risk factor for delayed graft function after deceased donor kidney transplantation. Am J Transplant. 2010 Feb; 10(2):298-303.
        View in: PubMed
      13. Gelb B, Feng S. Management of the liver transplant patient. Expert Rev Gastroenterol Hepatol. 2009 Dec; 3(6):631-47.
        View in: PubMed
      14. Feng S. Long-term management of immunosuppression after pediatric liver transplantation: is minimization or withdrawal desirable or possible or both? Curr Opin Organ Transplant. 2008 Oct; 13(5):506-12.
        View in: PubMed
      15. Yao FY, Kerlan RK, Hirose R, Davern TJ, Bass NM, Feng S, Peters M, Terrault N, Freise CE, Ascher NL, Roberts JP. Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis. Hepatology. 2008 Sep; 48(3):819-27.
        View in: PubMed
      16. Feng S. Steatotic livers for liver transplantation--life-saving but at a cost. Nat Clin Pract Gastroenterol Hepatol. 2008 Jul; 5(7):360-1.
        View in: PubMed
      17. Lan BY, Landry GM, Tan VO, Bostrom A, Feng S. Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis. Am J Transplant. 2008 Feb; 8(2):366-76.
        View in: PubMed
      18. Roayaie K, Feng S. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement? Liver Transpl. 2007 Nov; 13(11 Suppl 2):S36-43.
        View in: PubMed
      19. Gilmore AS, Helderman JH, Ricci JF, Ryskina KL, Feng S, Kang N, Legorreta AP. Linking the US transplant registry to administrative claims data: expanding the potential of transplant research. Med Care. 2007 Jun; 45(6):529-36.
        View in: PubMed
      20. Sekine S, GutiƩrrez PJ, Lan BY, Feng S, Hebrok M. Liver-specific loss of beta-catenin results in delayed hepatocyte proliferation after partial hepatectomy. Hepatology. 2007 Feb; 45(2):361-8.
        View in: PubMed
      21. Biggins SW, Feng S. In a MELD-based economy, how can we fight off inflation? Liver Transpl. 2007 Jan; 13(1):2-4.
        View in: PubMed
      22. Brennan TV, Bostrom A, Feng S. Optimizing living donor kidney graft function by donor-recipient pair selection. Transplantation. 2006 Sep 15; 82(5):651-6.
        View in: PubMed
      23. Rafaelian O, Coakley FV, Qayyum A, Breiman RS, Yeh BM, Joe BN, Westphalen AC, Feng S. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis? J Comput Assist Tomogr. 2006 Sep-Oct; 30(5):796-9.
        View in: PubMed
      24. Brennan TV, Fuller TF, Vincenti F, Chan S, Chang CK, Bostrom A, Zlatunich JK, Tomlanovich SJ, Feng S. Living donor kidney transplant recipients and clinical trials: participation profiles and impact on post-transplant care. Am J Transplant. 2006 Oct; 6(10):2429-35.
        View in: PubMed
      25. Merion RM, Goodrich NP, Feng S. How can we define expanded criteria for liver donors? J Hepatol. 2006 Oct; 45(4):484-8.
        View in: PubMed
      26. Feng S, Barr M, Roberts J, Oberbauer R, Kaplan B. Developments in clinical islet, liver thoracic, kidney and pancreas transplantation in the last 5 years. Am J Transplant. 2006 Aug; 6(8):1759-67.
        View in: PubMed
      27. Sekine S, Lan BY, Bedolli M, Feng S, Hebrok M. Liver-specific loss of beta-catenin blocks glutamine synthesis pathway activity and cytochrome p450 expression in mice. Hepatology. 2006 Apr; 43(4):817-25.
        View in: PubMed
      28. Feng S, Si M, Taranto SE, McBride MA, Mudge C, Stritzel S, Roberts JP, Rosenthal P. Trends over a decade of pediatric liver transplantation in the United States. Liver Transpl. 2006 Apr; 12(4):578-84.
        View in: PubMed
      29. Feng S, Goodrich NP, Bragg-Gresham JL, Dykstra DM, Punch JD, DebRoy MA, Greenstein SM, Merion RM. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006 Apr; 6(4):783-90.
        View in: PubMed
      30. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, Merriman R, Feng S, Freise CE, Ascher NL, Roberts JP. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005 Dec; 11(12):1505-14.
        View in: PubMed
      31. Fuller TF, Brennan TV, Feng S, Kang SM, Stock PG, Freise CE. End stage polycystic kidney disease: indications and timing of native nephrectomy relative to kidney transplantation. J Urol. 2005 Dec; 174(6):2284-8.
        View in: PubMed
      32. Carter JT, Chan S, Roberts JP, Feng S. Expanded criteria donor kidney allocation: marked decrease in cold ischemia and delayed graft function at a single center. Am J Transplant. 2005 Nov; 5(11):2745-53.
        View in: PubMed
      33. Feng S. Selecting livers for transplantation: can beggars be choosers? Nat Clin Pract Gastroenterol Hepatol. 2005 Nov; 2(11):496-7.
        View in: PubMed
      34. Magee JC, Feng S. PELD: working well, but only half of the time? Am J Transplant. 2005 Aug; 5(8):1785-6.
        View in: PubMed
      35. Carter JT, Freise CE, McTaggart RA, Mahanty HD, Kang SM, Chan SH, Feng S, Roberts JP, Posselt AM. Laparoscopic procurement of kidneys with multiple renal arteries is associated with increased ureteral complications in the recipient. Am J Transplant. 2005 Jun; 5(6):1312-8.
        View in: PubMed
      36. McTaggart RA, Tomlanovich SJ, Feng S. Impact of sirolimus on early graft function after deceased-donor kidney transplantation. Transplantation. 2005 Apr 27; 79(8):991; author reply 991-2.
        View in: PubMed
      37. Feng S, Humar A, Pomfret E, Fishbein T, Gaber O. Surgical challenges in transplantation: the Fourth Annual American Society of Transplant Surgeons' State-of-the-Art Winter Symposium. Am J Transplant. 2005 Mar; 5(3):428-35.
        View in: PubMed
      38. Feng S, Roberts J. An older liver in the hand, or a (possibly) younger liver in the bush? Am J Transplant. 2005 Mar; 5(3):425-7.
        View in: PubMed
      39. Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Posselt AM, Freise CE. BKV in simultaneous pancreas-kidney transplant recipients: a leading cause of renal graft loss in first 2 years post-transplant. Am J Transplant. 2005 Feb; 5(2):366-73.
        View in: PubMed
      40. Fernandes JR, Duvivier-Kali VF, Keegan M, Hollister-Lock J, Omer A, Su S, Bonner-Weir S, Feng S, Lee JS, Mulligan RC, Weir GC. Transplantation of islets transduced with CTLA4-Ig and TGFbeta using adenovirus and lentivirus vectors. Transpl Immunol. 2004 Nov; 13(3):191-200.
        View in: PubMed
      41. Fuller TF, Feng S, Brennan TV, Tomlanovich S, Bostrom A, Freise CE. Increased rejection in living unrelated versus living related kidney transplants does not affect short-term function and survival. Transplantation. 2004 Oct 15; 78(7):1030-5.
        View in: PubMed
      42. Beer S, Zetterberg A, Ihrie RA, McTaggart RA, Yang Q, Bradon N, Arvanitis C, Attardi LD, Feng S, Ruebner B, Cardiff RD, Felsher DW. Developmental context determines latency of MYC-induced tumorigenesis. PLoS Biol. 2004 Nov; 2(11):e332.
        View in: PubMed
      43. McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S. Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens. Transplantation. 2004 Aug 15; 78(3):475-80.
        View in: PubMed
      44. McTaggart RA, Terrault NA, Vardanian AJ, Bostrom A, Feng S. Hepatitis C etiology of liver disease is strongly associated with early acute rejection following liver transplantation. Liver Transpl. 2004 Aug; 10(8):975-85.
        View in: PubMed
      45. Takemoto SK, Zeevi A, Feng S, Colvin RB, Jordan S, Kobashigawa J, Kupiec-Weglinski J, Matas A, Montgomery RA, Nickerson P, Platt JL, Rabb H, Thistlethwaite R, Tyan D, Delmonico FL. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant. 2004 Jul; 4(7):1033-41.
        View in: PubMed
      46. Brennan TV, Freise CE, Fuller TF, Bostrom A, Tomlanovich SJ, Feng S. Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant. 2004 Jun; 4(6):971-9.
        View in: PubMed
      47. Freise CE, Kang SM, Feng S, Posselt A, Hirose K, Hirose R, Stock P. Experience with steroid-free maintenance immunosuppression in simultaneous pancreas-kidney transplantation. Transplant Proc. 2004 May; 36(4):1067-8.
        View in: PubMed
      48. Lipshutz GS, Mahanty H, Feng S, Hirose R, Stock PG, Kang SM, Freise CE. Polyomavirus-associated nephropathy in simultaneous kidney-pancreas transplant recipients: a single-center experience. Transplant Proc. 2004 May; 36(4):1097-8.
        View in: PubMed
      49. McTaggart RA, Feng S. An uncomfortable silence em leader while we all search for a better reporter gene in adult stem cell biology. Hepatology. 2004 Apr; 39(4):1143-6.
        View in: PubMed
      50. Vincenti F, Brennan TV, Fuller TF, Feng S. Optimizing the use of cyclosporine (Neoral) for recipients of living donor kidneys. Transplant Proc. 2004 Mar; 36(2 Suppl):50S-53S.
        View in: PubMed
      51. Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation. 2003 Dec 15; 76(11):1594-9.
        View in: PubMed
      52. Feng S, Buell JF, Chari RS, DiMaio JM, Hanto DW. Tumors and transplantation: The 2003 Third Annual ASTS State-of-the-Art Winter Symposium. Am J Transplant. 2003 Dec; 3(12):1481-7.
        View in: PubMed
      53. Lipshutz GS, Baxter-Lowe LA, Nguyen T, Jones KD, Ascher NL, Feng S. Death from donor-transmitted malignancy despite emergency liver retransplantation. Liver Transpl. 2003 Oct; 9(10):1102-7.
        View in: PubMed
      54. Freise CE, Kang SM, Feng S, Hirose R, Stock P. Excellent short-term results with steroid-free maintenance immunosuppression in low-risk simultaneous pancreas-kidney transplantation. Arch Surg. 2003 Oct; 138(10):1121-5; discussion 1125-6.
        View in: PubMed
      55. Fuller TF, Kang SM, Hirose R, Feng S, Stock PG, Freise CE. Management of lymphoceles after renal transplantation: laparoscopic versus open drainage. J Urol. 2003 Jun; 169(6):2022-5.
        View in: PubMed
      56. McTaggart RA, Gottlieb D, Brooks J, Bacchetti P, Roberts JP, Tomlanovich S, Feng S. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant. 2003 Apr; 3(4):416-23.
        View in: PubMed
      57. Metzger RA, Delmonico FL, Feng S, Port FK, Wynn JJ, Merion RM. Expanded criteria donors for kidney transplantation. Am J Transplant. 2003; 3 Suppl 4:114-25.
        View in: PubMed
      58. Feng S, Buell JF, Cherikh WS, Deng MC, Hanto DW, Kauffman HM, Leichtman AB, Lorber MI, Maters RG, McBride MA, Metzger RA, Nolte FS, O'Connor KJ, Roth D, Terrault NA, Henry ML. Organ donors with positive viral serology or malignancy: risk of disease transmission by transplantation. Transplantation. 2002 Dec 27; 74(12):1657-63.
        View in: PubMed
      59. Rosengard BR, Feng S, Alfrey EJ, Zaroff JG, Emond JC, Henry ML, Garrity ER, Roberts JP, Wynn JJ, Metzger RA, Freeman RB, Port FK, Merion RM, Love RB, Busuttil RW, Delmonico FL. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant. 2002 Sep; 2(8):701-11.
        View in: PubMed
      60. Chang GJ, Liu T, Feng S, Bedolli M, O'rourke RW, Schmidt G, Roberts JP, Stock PG. Targeted gene therapy with CD40Ig to induce long-term acceptance of liver allografts. Surgery. 2002 Aug; 132(2):149-56.
        View in: PubMed
      61. O'Rourke RW, Kang SM, Lower JA, Feng S, Ascher NL, Baekkeskov S, Stock PG. A dendritic cell line genetically modified to express CTLA4-IG as a means to prolong islet allograft survival. Transplantation. 2000 Apr 15; 69(7):1440-6.
        View in: PubMed
      62. Perini S, Gordon RL, LaBerge JM, Kerlan RK, Wilson MW, Feng S, Ring EJ. Transcatheter embolization of biopsy-related vascular injury in the transplant kidney: immediate and long-term outcome. J Vasc Interv Radiol. 1998 Nov-Dec; 9(6):1011-9.
        View in: PubMed
      Back to TOP